Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy
Conditions: Hepatocellular Carcinoma; Portal Vein Tumour Thrombosis Intervention: Combination Product: Neoadjuvant Sponsors: Ontario Clinical Oncology Group (OCOG); Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer & Oncology | Carcinoma | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Radiation Therapy | Research | Thrombosis